Skip to content

Clinical trials

Phase 2/3 Parasomnias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parasomnias Phase: Phase 2/3 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20131
20191
20201
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated2
Completed1
Not yet recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Vall d'Hebron1
M.D. Anderson Cancer Center1
Melissa Voigt Hansen1
Milton S. Hershey Medical Center1
Sixth Affiliated Hospital, Sun Yat-sen University1
University of Texas at Austin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parasomnias6
Anxiety Disorders2
Alcoholism1
Breast Neoplasms1
COVID-191
Cognitive Dysfunction1
Emergence Delirium1
Fatigue1
Fatigue Syndrome, Chronic1
Fractures, Stress1

Trials

Showing 51 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.